MacroGenics
MGNX
MGNX
113 hedge funds and large institutions have $583M invested in MacroGenics in 2017 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 48 increasing their positions, 29 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
0% more funds holding
Funds holding: 113 → 113 (0)
3.66% less ownership
Funds ownership: 89.48% → 85.82% (-3.7%)
Holders
113
Holding in Top 10
3
Calls
$824K
Puts
$600K
Top Buyers
| 1 | +$4.32M | |
| 2 | +$2.62M | |
| 3 | +$2.39M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$2.36M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$2.16M |
Top Sellers
| 1 | -$15.4M | |
| 2 | -$3.45M | |
| 3 | -$1.85M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$1.47M |
| 5 |
IBT
International Biotechnology Trust
London,
United Kingdom
|
-$945K |